Biomedicines (May 2022)

Peripheral Neuropathies Derived from COVID-19: New Perspectives for Treatment

  • Alfredo Córdova-Martínez,
  • Alberto Caballero-García,
  • Daniel Pérez-Valdecantos,
  • Enrique Roche,
  • David César Noriega-González

DOI
https://doi.org/10.3390/biomedicines10051051
Journal volume & issue
Vol. 10, no. 5
p. 1051

Abstract

Read online

Peripheral neuropathies constitute a group of disorders affecting the peripheral nervous system. Neuropathies have multiple causes such as infections (i.e., COVID-19), diabetes, and nutritional (low vitamin levels), among others. Many micronutrients, such as vitamins (A, C, D, E, B6, B12, and folate), certain minerals (Fe, Mg, Zn, Se, and Cu), and ω-3 fatty acids have immunomodulatory effects. Therefore, they may play an instrumental role in the treatment of COVID-19 infection. However, many COVID-19 patients can undergo neuropathy. In this context, there is a wealth of information on a variety of first-, second-, and third-line treatment options. This review focuses on the application of nutraceutical strategies in order to improve the symptomatology of neuropathy and neuropathic pain in patients that suffered from COVID-19. Our aim is to provide an alternative vision to traditional medical-pharmacological treatment through nutraceuticals.

Keywords